Earning the FDA’s prized Breakthrough Therapy designation is just the beginning of the race, one that likely requires the use of an imaging surrogate for preclinical evidence and accelerated approval. In these instances, imaging must be performed correctly, and results delivered quickly. This white paper presents how to get medical imaging done right in your Breakthrough Therapy trial.

Stay Updated

Never miss a beat. Sign up to receive emails covering industry news and useful content to help you advance clinical development.

  • This field is for validation purposes and should be left unchanged.